Ionis partner Novartis reports pelacarsen Phase 3 trial misses primary endpoint

Guardant Health wins FDA approval for Guardant360 CDx in advanced breast cancer

4basebio announces expansion of DNA offering for personalised mRNA medicines

Clover Biopharmaceuticals reports positive Phase 2 trial data for respiratory combination vaccine candidates

Rznomics reports advances in high-efficiency circRNA production in Nucleic Acids Research

Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA

Thryv Therapeutics licenses new class of SGK1 inhibitors, expanding into neurodegenerative disease

Sensorion secures French approval for Phase I/II SENS-601 hearing-loss trial

Foventa makes key CMO and CFO appointments

Akeso's ivonescimab meets overall survival endpoint in interim analysis of Phase III HARMONi-2 study

Teva reports positive Phase 2a data for TEV '408 in celiac disease

Ono Pharma partners with Aitia on neurological disease drug discovery

BioMarin completes Alesta Therapeutics acquisition

BioViva receives US patent for Klotho gene therapy targeting age-related cognitive decline

AstraZeneca completes global licence agreement for Zegfrovy